Serial #79294629
LIVE

Serial Number

79294629

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jul 16, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79294629 Trademark

Serial Number: 79294629 • Registration: 6422417

Serial #79294629 is a trademark filed by NOVARTIS AG on July 16, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

July 16, 2020

Registration Date

July 20, 2021

Published for Opposition

May 4, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 10, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Nov 26, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Nov 26, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 20, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 20, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 4, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 4, 2021 PUBO
NOTIFICATION PROCESSED BY IB
May 2, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 14, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 14, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 14, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 31, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 31, 2021 TROA
REFUSAL PROCESSED BY IB
Nov 22, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 4, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 4, 2020 RFRR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 2, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 2, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 2, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 2, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 2, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 2, 2020 COAR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 14, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 13, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 9, 2020 MAFR
ASSIGNED TO EXAMINER
Oct 6, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 5, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 2, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 1, 2020 REPR